| Literature DB >> 29441023 |
Jens-Uwe Werner1, Klaus Tödter2, Pengfei Xu1, Lydia Lockhart1, Markus Jähnert3, Pascal Gottmann3, Annette Schürmann3, Ludger Scheja2, Martin Wabitsch4, Uwe Knippschild1.
Abstract
Injury and obesity are two major health burdens affecting millions of people worldwide. Obesity is recognized as a state of chronic inflammation accompanied by various co-morbidities like T2D or cardiovascular diseases. There is increasing evidence that obesity impairs muscle regeneration, which is mainly due to chronic inflammation and to excessive accumulation of lipids in adipose and non-adipose tissue. To compare fatty acid profiles and changes in gene expression at different time points after muscle injury, we used an established drop tower-based model with a defined force input to damage the extensor iliotibialis anticus on the left hind limb of female C57BL/6J mice of normal weight and obese mice. Although most changes in fatty acid content in muscle tissue are diet related, levels of eicosaenoic (normal weight) and DHG-linolenic acid (obese) in the phospholipid and docosahexaenoic acid (normal weight) in the triglyceride fraction are altered after injury. Furthermore, changes in gene transcription were detected in 3829 genes in muscles of normal weight mice, whereas only 287 genes were altered in muscles of obese mice after trauma. Alterations were found within several pathways, among them notch-signaling, insulin-signaling, sonic hedgehog-signaling, apoptosis related pathways, fat metabolism related cholesterol homeostasis, fatty acid biosynthetic process, fatty acid elongation, and acyl-CoA metabolic process. We could show that genes involved in fat metabolism are affected 3 days after trauma induction mostly in normal weight but not in obese mice. The strongest effects were observed in normal weight mice for Alox5ap, the activating protein for leukotriene synthesis, and Apobec1, an enzyme substantial for LDL synthesis. In summary, we show that obesity changes the fat content of skeletal muscle and generally shows a negative impact upon blunt muscle injury on various cellular processes, among them fatty acid related metabolism, notch-, insulin-, sonic hedgehog-signaling, and apoptosis.Entities:
Keywords: Alox5ap; Apobec1; C57BL/6J; fatty acid; injury; obesity; skeletal muscle
Year: 2018 PMID: 29441023 PMCID: PMC5797686 DOI: 10.3389/fphys.2018.00019
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Characteristics for animals used for induction of a blunt muscle trauma.
| Diet | D12450J | D12492 | ||
| Normal (ND) | High fat (HFD) | |||
| 10% kcal fat | 60% kcal fat | |||
| Strain | C57BL/6J | |||
| n = | 18 | 18 | 18 | 18 |
| Age [week] | 16.3 ± 0.69 | 16.5 ± 0.52 | 16.3 ± 0.73 | 16.4 ± 0.69 |
| Body weight [g] | 21.4 ± 1.02 | 21.7 ± 1.67 | 33.1 ± 4.67 | 32.4 ± 3.54 |
Age and body weight are depicted as mean ± standard deviation.
Figure 1Body weight of animals and significant differences of our cohort. Values are given with mean ±standard deviation; n = 18 per group. Statistical analysis by two-sided homoscedastic t-test. *Indicates p ≤ 0.01.
Effect of blunt muscle injury on the weight of normal weight and obese animals.
| 1 h | 21.4 | ±1.74 | n.m. | 31.2 | ±5.48 | n.m. | ||
| 6 h | 21.3 | ±1.33 | n.m. | 32.6 | ±1.91 | n.m. | ||
| 24 h | 20.0 | ±1.15 | 19.8 | ±0.70 | 25.4 | ±4.56 | 24.4 | ±4.08 |
| 3 d | 19.5 | ±0.57 | 20.1 | ±0.75 | 28.0 | ±5.84 | 27.9 | ±5.76 |
| 8 d | 20.7 | ±1.19 | 21.1 | ±1.95 | 31.2 | ±0.51 | 31.7 | ±0.32 |
| 1 h | 22.4 | ±0.78 | n.m. | 28.3 | ±4.57 | n.m. | ||
| 6 h | 22.5 | ±1.39 | n.m. | 34.9 | ±5.00 | n.m. | ||
| 24 h | 21.2 | ±0.36 | 20.5 | ±0.46 | 26.3 | ±4.31 | 26.4 | ±4.18 |
| 3 d | 20.9 | ±1.42 | 20.7 | ±1.46 | 29.3 | ±0.40 | 27.6 | ±2.01 |
| 8 d | 22.1 | ±2.82 | 21.6 | ±1.86 | 29.6 | ±2.75 | 29.3 | ±2.56 |
All animals were weighed before and at different time points after muscle injury. Weight loss was only noted after trauma with slight decreases for both, normal weight and obese animals. Values are depicted as average in grams ±standard deviation per group; n.m., not measured.
Figure 2Hematoxylin-eosin (HE) staining of muscle tissue sections from female normal weight and obese mice for control, 24 h and 8 d after blunt injury induction. Muscle damage and myofiber regeneration are visible. Pictures were taken with Olympus IX81 using Xcellence v.1.2. Scale = 50 μm at 40x magnification.
Blunt muscle injury to extensor iliotibialis anticus results in similar muscle damage but to an increased fibrosis formation in obese mice compared to normal weight mice.
| Interstitial fluid, edema and hemorrhage exudate | Formation of interstitial fluid, edema and hemorrhage exudate already 1 h after injury detectable | Interstitial fluid, edema and hemorrhage exudate formation as in normal weight animals |
| Morphology | Disruption of tissue, peak inflammation 24 h after injury. Regeneration was completed after 21 day | Disruption of tissue, peak inflammation 2 days delayed. Muscle regeneration still incomplete after 21 days |
Figure 3(A) Ratios grouped into saturated (SFA), monounsaturated (MUFA) and polyunsaturated (PUFA) fatty acids for phospholipid and triglyceride fractions respectively. Injury influenced MUFA in both groups and PUFA notably in obese mice in phospholipid fraction. SFA was higher in normal weight controls. Phospholipid SFAs did not change, while MUFAs were higher and PUFAs lower in normal weight mice (B). Triglyceride SFAs were higher and PUFAs were lower in normal weight mice. MUFA content did not change. Trauma includes 1, 6, 24 h, 3, 8, and 21 d. NC, Normal (Control); NT, Normal (Trauma); OC, Obese (Control); and OT, Obese (Trauma).
FA-composition of phospholipid fraction in muscle tissue.
| Myristic (14:0) | 1.106 | ±0.045 | 1.160 | ±0.345 | 0.779 | ±0.081 | 0.771 | ±0.054 |
| Myristoleic (14:1) | n.d. | n.d. | n.d. | n.d. | ||||
| Palmitic (16:0) | 27.696 | ±1.153 | 27.518 | ±1.278 | 26.779 | ±1.671 | 26.962 | ± 1.404 |
| d-7-hexadecenoic (16:1) | 0.766 | ±0.114 | 0.808 | ±0.128 | 0.668 | ±0.092 | 0.669 | ±0.090 |
| Palmitoleic (16:1) | 2.090 | ±0.235 | 2.142 | ±0.258 | 0.694 | ±0.110 | 0.731 | ± 0.118 |
| Stearic (18:0) | 16.266 | ±1.803 | 16.712 | ±0.914 | 18.706 | ±1.554 | 18.842 | ± 2.183 |
| Oleic (18:1) | 6.518 | ±1.866 | 6.842 | ±1.700 | 5.262 | ±0.821 | 5.801 | ±1.273 |
| Vaccenic (18:1) | 4.472 | ±0.313 | 4.425 | ±0.359 | 3.261 | ±0.250 | 3.224 | ±0.180 |
| Linoleic (18:2) | 7.482 | ±0.707 | 7.851 | ±0.938 | 9.384 | ±1.365 | 8.912 | ±1.084 |
| g-Linolenic (18:3) | 0.082 | ±0.010 | 0.085 | ±0.008 | 0.056 | ±0.007 | 0.070 | ± 0.058 |
| Linolenic (18:3) | 0.548 | ±0.047 | 0.549 | ±0.061 | 0.411 | ±0.176 | 0.616 | ±1.036 |
| Stearidonic (18:4) | n.d. | n.d. | n.d. | n.d. | ||||
| Arachidic (20:0) | 0.230 | ±0.128 | 0.203 | ±0.104 | 0.192 | ±0.109 | 0.210 | ±0.107 |
| Eicosenoic (20:1) | 0.176 | ±0.020 | 0.194 | ±0.029 | 0.145 | ±0.018 | 0.151 | ±0.021 |
| Eicosadienoic (20:2) | 0.283 | ±0.035 | 0.315 | ±0.058 | 0.803 | ±0.074 | 0.785 | ± 0.061 |
| DHG-Linolenic (20:3) | 0.925 | ±0.067 | 0.903 | ±0.078 | 0.761 | ±0.063 | 0.716 | ±0.048 |
| Arachidonic (20:4) | 11.976 | ±0.924 | 11.843 | ±0.794 | 10.756 | ±1.157 | 10.309 | ± 0.666 |
| Eicosatrienoic (20:3) | n.d. | n.d. | n.d. | n.d. | ||||
| Eicosatetraenoic (20:4) | n.d. | n.d. | n.d. | n.d. | ||||
| Eicosapentaenoic (20:5) | 0.076 | ±0.023 | 0.082 | ±0.008 | 0.055 | ±0.015 | 0.055 | ±0.014 |
| Behenic (22:0) | 0.346 | ±0.297 | 0.304 | ±0.219 | 0.181 | ±0.027 | 0.215 | ±0.109 |
| Erucic (22:1) | 0.094 | ±0.017 | 0.099 | ±0.027 | 0.056 | ±0.017 | 0.056 | ±0.016 |
| Docosapentaenoic (22:5) | 1.144 | ±0.132 | 1.214 | ±0.129 | 2.152 | ±0.163 | 2.095 | ±0.178 |
| Docosahexaenoic (22:6) | 16.665 | ±2.454 | 15.755 | ±1.726 | 18.221 | ±1.278 | 18.021 | ±1.479 |
| Lignoceric (24:0) | 0.499 | ±0.538 | 0.413 | ±0.383 | 0.262 | ±0.056 | 0.319 | ± 0.210 |
| Nervonic (24:1) | 0.501 | ±0.342 | 0.510 | ±0.301 | 0.258 | ±0.041 | 0.308 | ±0.134 |
Values are depicted as mean ±standard deviation of total fatty acid fraction percentage; n = 18 per group. N.d., not detected. Muscle tissue from injured animals showed a significant influence (gray shade) on eicosenoic (ND, CvT) and DHG-linolenic acid (HFD, CvT) with p ≤ 0.05. Different depiction can be found in Supplementary Figure .
FA-composition of triglyceride fraction in muscle tissue.
| Myristic (14:0) | 2.089 | ±0.196 | 2.032 | ±0.158 | 1.189 | ±0.112 | 1.154 | ±0.076 |
| Myristoleic (14:1) | 0.162 | ±0.047 | 0.164 | ±0.046 | 0.052 | ±0.016 | 0.051 | ± 0.010 |
| Palmitic (16:0) | 26.202 | ±2.709 | 25.605 | ±1.803 | 20.582 | ±0.618 | 20.386 | ± 0.844 |
| d-7-hexadecenoic (16:1) | 0.819 | ±0.078 | 0.756 | ±0.115 | 0.768 | ±0.049 | 0.796 | ±0.049 |
| Palmitoleic (16:1) | 8.361 | ±1.645 | 8.379 | ±2.009 | 4.496 | ±0.807 | 4.518 | ± 0.494 |
| Stearic (18:0) | 8.178 | ±4.415 | 7.050 | ±1.731 | 6.026 | ±0.804 | 6.224 | ±1.271 |
| Oleic (18:1) | 37.411 | ±4.118 | 38.995 | ±2.252 | 40.837 | ±1.182 | 41.204 | ±1.700 |
| Vaccenic (18:1) | 3.313 | ±0.531 | 3.098 | ±0.345 | 3.043 | ±0.483 | 2.897 | ±0.270 |
| Linoleic (18:2) | 10.988 | ±2.090 | 11.357 | ±1.754 | 19.697 | ±0.723 | 19.555 | ± 0.788 |
| g-Linolenic (18:3) | 0.078 | ±0.021 | 0.071 | ±0.009 | 0.051 | ±0.006 | 0.053 | ± 0.009 |
| Linolenic (18:3) | 0.703 | ±0.269 | 0.639 | ±0.077 | 0.958 | ±0.126 | 0.908 | ±0.081 |
| Stearidonic (18:4) | n.d. | n.d. | n.d. | n.d. | ||||
| Arachidic (20:0) | 0.174 | ±0.081 | 0.160 | ±0.042 | 0.106 | ±0.065 | 0.096 | ±0.024 |
| Eicosenoic (20:1) | 0.638 | ±0.086 | 0.667 | ±0.125 | 0.540 | ±0.090 | 0.529 | ± 0.046 |
| Eicosadienoic (20:2) | 0.193 | ±0.021 | 0.201 | ±0.039 | 0.544 | ±0.039 | 0.529 | ± 0.032 |
| DHG-Linolenic (20:3) | 0.126 | ±0.016 | 0.122 | ±0.020 | 0.168 | ±0.015 | 0.166 | ± 0.017 |
| Arachidonic (20:4) | 0.304 | ±0.058 | 0.333 | ±0.077 | 0.466 | ±0.066 | 0.459 | ± 0.054 |
| Eicosatrienoic (20:3) | n.d. | n.d. | n.d. | n.d. | ||||
| Eicosatetraenoic (20:4) | n.d. | n.d. | n.d. | n.d. | ||||
| Eicosapentaenoic (20:5) | 0.017 | ±0.004 | 0.018 | ±0.005 | 0.036 | ±0.007 | 0.033 | ±0.007 |
| Behenic (22:0) | 0.048 | ±0.012 | 0.049 | ±0.014 | 0.034 | ±0.007 | 0.035 | ±0.009 |
| Erucic (22:1) | 0.065 | ±0.019 | 0.063 | ±0.014 | 0.024 | ±0.006 | 0.024 | ±0.007 |
| Docosapentaenoic (22:5) | 0.068 | ±0.021 | 0.072 | ±0.021 | 0.101 | ±0.008 | 0.097 | ±0.010 |
| Docosahexaenoic (22:6) | 0.155 | ±0.019 | 0.190 | ±0.044 | 0.242 | ±0.029 | 0.239 | ±0.025 |
| Lignoceric (24:0) | 0.034 | ±0.012 | 0.034 | ±0.016 | 0.022 | ±0.008 | 0.022 | ± 0.008 |
| Nervonic (24:1) | 0.037 | ±0.014 | 0.032 | ±0.015 | 0.025 | ±0.015 | 0.028 | ±0.030 |
Values are depicted as mean ± standard deviation of total fatty acid fraction percentage; n = 18 per group. N.d., not detected. Injury showed a significant influence (gray shade) on docosahexaenoic acid (ND, CvT) with p ≤ 0.05. Different depiction can be found in Supplementary Figure .
Expression levels of genes involved in fatty acid metabolism determined by microarray analysis.
| 1.03 | −1.15 | −1.09 | −1.32 | −1.35 | 1.55 | 1.19 | −1.03 | 1.03 | ||
| 1.47 | 1.49 | 1.41 | 1.82 | 1.26 | 1.22 | 1.73 | 2.33 | 1.28 | ||
| 1.12 | 1.43 | 1.18 | 1.93 | 1.17 | 1.33 | 1.40 | 2.93 | 1.23 | ||
| −1.12 | 1.01 | 1.12 | 1.04 | −1.08 | −1.17 | 1.17 | −1.36 | −1.07 | ||
| 1.06 | 1.26 | 1.12 | 1.38 | 1.13 | 1.24 | 1.15 | 1.29 | 1.14 | ||
| 1.20 | 1.01 | 1.13 | −1.37 | −1.13 | 1.11 | 2.20 | 1.24 | |||
| 1.27 | 1.17 | 1.11 | 1.46 | −1.05 | 1.21 | 1.15 | 1.55 | 1.06 | ||
| 1.25 | 1.04 | −1.13 | 1.36 | −1.09 | 1.05 | −1.07 | 1.10 | 1.15 | ||
| −1.02 | −1.10 | −1.47 | −1.03 | 1.13 | −1.07 | −1.49 | −1.25 | 1.14 | ||
| 1.02 | −1.09 | 1.02 | 1.06 | −1.01 | −1.21 | −1.08 | 1.35 | 1.03 | ||
| 1.41 | 1.04 | 1.34 | −1.60 | 1.06 | 1.22 | 2.76 | 1.04 | |||
| 1.01 | −1.05 | 1.10 | −1.13 | −1.14 | 1.21 | 1.59 | 1.12 | |||
| 2.20 | 5.09 | 2.28 | −1.12 | 5.65 | 1.91 | 5.93 | 1.68 | 1.07 | ||
| 1.18 | 1.69 | −1.03 | 1.03 | 1.33 | 1.89 | 1.22 | −1.04 | 1.00 | ||
| 1.24 | −1.18 | −1.42 | −1.37 | 1.04 | −1.12 | −1.36 | −1.24 | 1.13 | ||
| 1.25 | 1.24 | −1.01 | 1.55 | −1.07 | 1.01 | 1.22 | 1.50 | 1.14 | ||
| −1.12 | −1.11 | 1.21 | −1.46 | −1.00 | −1.25 | −1.37 | −1.58 | −1.09 | ||
| 1.43 | −1.02 | 1.05 | 2.47 | 1.00 | −1.03 | −1.17 | 2.03 | |||
| 1.05 | 1.01 | 1.09 | 1.06 | −1.10 | −1.05 | −1.17 | −1.00 | |||
| −1.14 | −1.03 | −1.06 | 1.19 | 1.03 | −1.10 | −1.00 | 1.04 | 1.14 | ||
| 1.04 | 1.08 | 1.09 | 1.30 | 1.08 | 1.14 | 1.05 | 1.07 | |||
Significantly up-regulated genes (p ≤ 0.05) are shown in bold letters with background color (red = up-; green = down-regulated). Genes selected for validation are in bold. Description of genes and corresponding significance levels can be found in Supplement .
Figure 4Expression levels of Alox5ap (A) and Apobec1 (B) as determined by microarray analysis. Ticked line(s) at 1 represents basal level. *p ≤ 0.05. Expression levels of Alox5ap (C) and Apobec1 (D) quantified by qPCR. X-fold values ±SEM were determined by normalization on corresponding controls of each time point and diet. Genes show the highest differential expression 3 days post-injury, while obese animals show a lack of response to trauma, overall indicating a direct influence of injury. Apobec1 (D) shows a unidirectional response despite the higher SEM. Both genes show a similar behavior in microarray and qPCR. Significance of qPCR was determined using ANOVA.
Expression levels of genes associated with notch, insulin, sonic hedgehog (Shh) and apoptosis.
| 1.19 | 1.11 | 1.06 | 1.11 | 1.13 | −1.20 | 1.12 | 1.16 | ||||
| 1.22 | 1.09 | −1.09 | 1.18 | 1.03 | 1.04 | 1.23 | 1.09 | ||||
| −1.03 | 1.09 | 1.20 | 1.49 | −1.26 | −1.09 | 1.65 | 1.15 | ||||
| 1.33 | 1.49 | 1.00 | 1.50 | 1.13 | 1.13 | 1.24 | 1.45 | 1.19 | |||
| −1.02 | 1.16 | 1.20 | 1.49 | 1.01 | 1.09 | 1.20 | 1.07 | 1.00 | |||
| −1.02 | −1.08 | −1.09 | −1.08 | −1.09 | −1.05 | −1.01 | −1.02 | ||||
| 1.38 | 1.05 | −1.17 | −1.05 | 1.10 | −1.06 | 1.08 | 1.30 | ||||
| 1.37 | 1.13 | 1.50 | 1.08 | 1.20 | 1.21 | 1.95 | 1.07 | ||||
| −1.01 | 1.05 | 1.11 | −1.10 | −1.15 | 1.09 | ||||||
| −1.09 | 1.06 | −1.01 | −1.09 | −1.13 | −1.11 | ||||||
| 1.07 | 1.11 | 1.15 | 1.33 | −1.12 | 1.06 | 1.01 | 1.02 | −1.01 | |||
| 1.10 | 1.08 | −1.21 | −1.07 | −1.25 | 1.16 | 1.14 | −1.08 | 1.04 | |||
| 1.19 | 1.62 | 1.23 | 1.07 | 1.03 | 1.24 | 1.15 | 1.20 | −1.03 | |||
| −1.19 | −1.16 | −1.10 | −1.35 | −1.19 | −1.16 | −1.03 | −1.07 | −1.07 | |||
| 1.14 | 1.10 | −1.00 | 1.06 | −1.17 | −1.08 | 1.10 | |||||
| 1.20 | 1.08 | 1.07 | −1.06 | 1.02 | 1.07 | −1.00 | |||||
| 2.67 | 2.06 | 2.66 | 1.30 | 2.27 | 1.38 | 1.04 | −1.36 | ||||
| −1.32 | 1.01 | −1.15 | −1.19 | 1.14 | 1.15 | 1.04 | |||||
| −1.07 | 1.18 | 1.07 | 1.20 | −1.02 | 1.01 | −1.04 | 1.05 | 1.01 | |||
| 1.08 | −1.24 | 1.08 | 1.26 | 1.04 | 1.01 | 1.06 | 1.15 | 1.04 | |||
| 1.17 | −1.06 | 1.30 | −1.07 | 1.12 | 1.02 | 1.26 | 1.20 | ||||
| −1.34 | 3.56 | −1.00 | −1.24 | −1.09 | 1.52 | 1.09 | |||||
| −1.01 | −1.02 | −1.12 | −1.05 | 1.02 | −1.09 | −1.06 | −1.00 | ||||
| −1.00 | −1.05 | 1.08 | −1.02 | 1.14 | 1.10 | 1.27 | 1.02 | ||||
| 1.02 | −1.26 | −1.10 | 1.43 | −1.16 | 1.22 | −1.01 | 1.16 | 1.12 | |||
| 1.31 | 1.40 | 1.46 | 1.58 | 1.09 | 1.49 | 1.38 | 1.92 | 1.12 | |||
| −1.09 | −1.07 | 1.05 | 1.17 | 1.00 | −1.06 | 1.02 | 1.25 | 1.02 | |||
| 1.02 | 1.01 | 1.08 | 1.17 | −1.01 | −1.01 | 1.14 | 1.13 | −1.03 | |||
| 1.86 | 2.07 | −1.02 | 1.27 | 3.00 | 1.58 | 1.10 | 1.02 | ||||
| 1.19 | 1.06 | 1.17 | 1.28 | −1.13 | −1.05 | −1.01 | −1.06 | ||||
| 1.25 | 1.25 | −1.00 | 1.05 | 1.15 | 1.17 | 1.03 | 1.06 | −1.01 | |||
| 1.40 | 1.05 | 1.00 | 1.06 | 1.05 | 1.10 | 1.06 | 1.05 | 1.04 | |||
| 1.23 | 1.02 | 1.09 | 1.29 | 1.04 | 1.06 | 1.18 | 1.19 | ||||
| 2.08 | 1.41 | 1.02 | 1.02 | 1.33 | −1.05 | 1.10 | 1.07 | ||||
| −1.01 | 1.73 | 1.27 | 1.09 | 1.28 | 1.10 | ||||||
| 1.38 | 1.28 | −1.25 | 1.09 | 1.03 | 1.29 | −1.00 | 1.03 | 1.28 | |||
| −1.07 | 1.04 | 2.46 | 1.07 | 1.28 | 1.06 | 1.16 | −1.17 | ||||
| 1.18 | 1.27 | −1.42 | 1.00 | 1.06 | 1.01 | −1.27 | −1.08 | 1.05 | |||
| Shared with | |||||||||||
| −1.19 | 1.01 | 1.04 | −1.06 | −1.12 | −1.09 | −1.01 | −1.01 | Apoptosis Insulin | |||
| 1.04 | 1.39 | 1.00 | 1.10 | −1.38 | −1.09 | 1.32 | |||||
| −1.10 | −1.10 | 1.10 | 1.18 | −1.12 | −1.01 | 1.14 | −1.03 | ||||
| 1.21 | 1.10 | −1.03 | 1.12 | 1.09 | 1.19 | 1.05 | 1.05 | 1.20 | |||
| 1.12 | −1.15 | 1.36 | 1.10 | 1.17 | 1.07 | 1.63 | 1.08 | ||||
| 1.09 | −1.31 | −1.13 | −1.26 | −1.37 | −1.01 | 1.01 | |||||
| 1.65 | 1.27 | 1.07 | 1.44 | 1.40 | 1.45 | 1.20 | 1.68 | 1.11 | |||
| −1.05 | −1.11 | −1.03 | 1.02 | −1.10 | 1.04 | 1.04 | |||||
| 1.08 | 1.02 | 1.05 | 1.04 | −1.12 | 1.07 | 1.22 | 1.07 | ||||
| 1.19 | −1.13 | 1.03 | 1.36 | 1.06 | 1.73 | 1.10 | |||||
| 1.13 | 1.14 | 1.27 | 1.41 | −1.20 | 1.03 | 1.30 | 1.48 | 1.00 | |||
| 1.02 | 1.16 | −1.11 | 1.06 | 1.21 | 1.10 | 1.04 | 1.06 | 1.14 | |||
| 1.27 | 1.12 | −1.04 | 1.17 | 1.04 | 1.23 | 1.08 | 1.11 | 1.10 | |||
| 1.05 | −1.11 | −1.10 | 1.03 | 1.10 | −1.08 | −1.12 | −1.05 | −1.06 | |||
| 1.01 | −1.05 | −1.03 | −1.02 | −1.06 | −1.01 | −1.13 | 1.01 | −1.05 | |||
| 1.12 | 1.07 | −1.17 | 1.30 | 1.03 | 1.13 | −1.13 | −1.00 | 1.07 | Insulin Shh | ||
| −1.02 | −1.09 | 1.06 | −1.10 | −1.13 | 1.00 | 1.05 | −1.11 | ||||
| −1.08 | −1.15 | −1.01 | −1.18 | −1.08 | 1.03 | 1.20 | −1.17 | ||||
| −1.09 | −1.04 | −1.04 | −1.29 | −1.00 | −1.05 | 1.00 | −1.07 | ||||
| −1.34 | −1.37 | 1.53 | −1.20 | −1.41 | −1.30 | 1.56 | 1.29 | −1.02 | |||
| −1.25 | −1.14 | 1.02 | −1.21 | −1.11 | 1.08 | 1.04 | −1.04 | ||||
The shared section includes genes involved in at least 2 pathways. Significantly up-regulated genes (p ≤ 0.05) are shown in bold letters with background color (red = up-; green = down-regulated). Description of genes and corresponding significance levels can be found in Supplement .